loadpatents
Patent applications and USPTO patent grants for Baba; Masanori.The latest application filed is for "bicyclic compound, production and use thereof".
Patent | Date |
---|---|
Antiviral drug for severe fever with thrombocytopenia syndrome Grant 11,001,557 - Baba , et al. May 11, 2 | 2021-05-11 |
Anti-hepatoma-virus agent Grant 10,987,372 - Ikeda , et al. April 27, 2 | 2021-04-27 |
Bicyclic Compound, Production And Use Thereof App 20200297700 - SHIRAISHI; Mitsuru ;   et al. | 2020-09-24 |
Novel Amodiaquine Analogs And Methods Of Uses Thereof App 20200113891 - DAVEY; Robert A. ;   et al. | 2020-04-16 |
Antiviral Drug For Severe Fever With Thrombocytopenia Syndrome App 20190389803 - BABA; Masanori ;   et al. | 2019-12-26 |
Anti-hepatoma-virus Agent App 20190070207 - IKEDA; Masanori ;   et al. | 2019-03-07 |
Bicyclic Compound, Production And Use Thereof App 20190038604 - SHIRAISHI; Mitsuru ;   et al. | 2019-02-07 |
Bicyclic compound, production and use thereof Grant 10,045,968 - Shiraishi , et al. August 14, 2 | 2018-08-14 |
Bicyclic Compound, Production And Use Thereof App 20160008326 - SHIRAISHI; Mitsuru ;   et al. | 2016-01-14 |
Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections Grant 9,126,971 - Cheng , et al. September 8, 2 | 2015-09-08 |
Method Using Glycan Immobilized Metal Nanoparticles For Early Hiv-1 Detection App 20150218661 - SUDA; Yasuo ;   et al. | 2015-08-06 |
Polyion complex comprising hydrophobized polyamino acid and use of the same Grant 8,853,354 - Baba , et al. October 7, 2 | 2014-10-07 |
Therapeutic drug for adult T-cell leukemia Grant 8,765,719 - Baba , et al. July 1, 2 | 2014-07-01 |
Bicyclic compound, production and use thereof Grant 8,741,943 - Shiraishi , et al. June 3, 2 | 2014-06-03 |
Communication device, power supplying method therefor, and power supply system Grant 8,724,277 - Baba , et al. May 13, 2 | 2014-05-13 |
Glycan Immobilized Metal Nanoparticles And Use Thereof For Early Hiv-1 Detection App 20140045169 - SUDA; Yasuo ;   et al. | 2014-02-13 |
Bicyclic compound, production and use thereof Grant 8,362,058 - Shiraishi , et al. January 29, 2 | 2013-01-29 |
Therapeutic Agent For Hepatitis C App 20120316342 - Baba; Masanori ;   et al. | 2012-12-13 |
Anti-viral Nucleoside Analogs And Methods For Treating Viral Infections, Especially Hiv Infections App 20120252751 - Cheng; Yung-chi ;   et al. | 2012-10-04 |
Bicyclic Compound, Production and Use Thereof App 20120232028 - SHIRAISHI; Mitsuru ;   et al. | 2012-09-13 |
Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections Grant 8,193,165 - Cheng , et al. June 5, 2 | 2012-06-05 |
Bicyclic compound, production and use thereof Grant 8,183,273 - Shiraishi , et al. May 22, 2 | 2012-05-22 |
Polyion Complex Comprising Hydrophobized Polyamino Acid And Use Of The Same App 20120095186 - Baba; Masanori ;   et al. | 2012-04-19 |
Communication Device, Power Supplying Method Therefor, And Power Supply System App 20110310519 - BABA; Masanori ;   et al. | 2011-12-22 |
Polyamino acid for use as adjuvant Grant 8,017,154 - Akashi , et al. September 13, 2 | 2011-09-13 |
Therapeutic Drug For Adult T-cell Leukemia App 20110172185 - Baba; Masanori ;   et al. | 2011-07-14 |
Human Antibody Capable Of Inducing Apoptosis App 20110117602 - Ito; Yuji ;   et al. | 2011-05-19 |
Anti-viral Agent Containing Heterocyclic Aromatic Compound As Active Ingredient App 20100256379 - Baba; Masanori ;   et al. | 2010-10-07 |
Polyamino acid for use as adjuvant Grant 7,785,612 - Akashi , et al. August 31, 2 | 2010-08-31 |
Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections App 20100048500 - Cheng; Yung-chi ;   et al. | 2010-02-25 |
Polyamino acid for use as adjuvant App 20090285901 - Akashi; Mitsuru ;   et al. | 2009-11-19 |
Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections Grant 7,589,078 - Cheng , et al. September 15, 2 | 2009-09-15 |
Polyamino acid for use as adjuvant App 20090092633 - Akashi; Mitsuru ;   et al. | 2009-04-09 |
Bicyclic Compound, Production and Use Thereof App 20090030032 - Shiraishi; Mitsuru ;   et al. | 2009-01-29 |
Bicyclic compound, production and use thereof App 20080161287 - Shiraishi; Mitsuru ;   et al. | 2008-07-03 |
Bicyclic compound, production and use thereof Grant 7,371,772 - Shiraishi , et al. May 13, 2 | 2008-05-13 |
Cyclic amine compounds as CCR5 antagonists Grant 7,348,324 - Imamura , et al. March 25, 2 | 2008-03-25 |
Fused-ring pyridine derivative, process for producing the same, and use Grant 7,288,654 - Shiraishi , et al. October 30, 2 | 2007-10-30 |
Benzazepine derivative, process for producing the same, and use Grant 7,262,185 - Shiraishi , et al. August 28, 2 | 2007-08-28 |
Tricyclic compound, process for producing the same, and use App 20060178359 - Shiraishi; Mitsuru ;   et al. | 2006-08-10 |
Acrylamide derivative, process for producing the same, and use App 20060160864 - Shiraishi; Mitsuru ;   et al. | 2006-07-20 |
Fused-ring pyridine derivative, process for producing the same, and use App 20060100197 - Shiraishi; Mitsuru ;   et al. | 2006-05-11 |
Benzazepine derivatives, process for the preparation of the same and uses thereof Grant 6,936,602 - Shiraishi , et al. August 30, 2 | 2005-08-30 |
Preventives for hiv infection App 20050154016 - Takashima, Katsunori ;   et al. | 2005-07-14 |
Bicyclic compound, production and use thereof App 20040259876 - Shiraishi, Mitsuru ;   et al. | 2004-12-23 |
Benzazepine derivative, process for producing the same, and use App 20040235822 - Shiraishi, Mitsuru ;   et al. | 2004-11-25 |
Urea compounds, process for producing the same and use thereof Grant 6,787,650 - Kurasawa , et al. September 7, 2 | 2004-09-07 |
Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections App 20040167096 - Cheng, Yung-chi ;   et al. | 2004-08-26 |
T cell line and use thereof App 20040043380 - Miyake, Hiroshi ;   et al. | 2004-03-04 |
Cyclic compounds and uses thereof Grant 6,627,651 - Shiraishi , et al. September 30, 2 | 2003-09-30 |
Impulse noise rejection circuit and satellite communications terminal using the same Grant 6,615,022 - Baba September 2, 2 | 2003-09-02 |
Cyclic amine compounds as CCR5 antagonists App 20030114443 - Imamura, Shinichi ;   et al. | 2003-06-19 |
HIV-producing cell line and uses thereof App 20030109023 - Miyake, Hiroshi ;   et al. | 2003-06-12 |
Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative Grant 6,268,354 - Nishimura , et al. July 31, 2 | 2001-07-31 |
Anilide derivative, production and use thereof Grant 6,235,771 - Shiraishi , et al. May 22, 2 | 2001-05-22 |
Quaternary ammonium salts and their use Grant 6,096,780 - Shiraishi , et al. August 1, 2 | 2000-08-01 |
Pyrimidine derivatives and anti-viral agent containing the same as active ingredient thereof Grant 5,461,060 - Miyasaka , et al. October 24, 1 | 1995-10-24 |
Pyrimidine nucleoside derivative and antiviral agent containing the derivative as active ingredient Grant 5,318,972 - Miyasaka , et al. * June 7, 1 | 1994-06-07 |
Sulphated vinyl polymers in compositions for treating retroviral infections Grant 5,152,978 - Baba , et al. October 6, 1 | 1992-10-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.